Potential value and limitation of dual inhibitors of pi3k and mtor in the treatment of cancer
RIS ID
78982
Abstract
The critical roles of the phosphoinositied 3-kinase (PI3K) pathway in many cancers have been extensively studied and reviewed. Activation of the pathway has been associated with carcinogenesis, cancer maintenance and drug resistance.
COinS
Publication Details
Chen, J. (2013). Potential value and limitation of dual inhibitors of pi3k and mtor in the treatment of cancer. Current Cancer Drug Targets, 13 (2), 117-120.